The Daily

The Daily

This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro, Rachel Abrams and Natalie Kitroeff. Twenty minutes a day, six days a week, ready by 6 a.m. Subscribe today at nytimes.com/podcasts or on Apple Podcasts, Spotify and Amazon Music. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher.
00:00
00:00

Episode's summary

This episode explores a breakthrough in cancer treatment involving an individualized mRNA vaccine for melanoma, which has been shown to reduce the risk of recurrence by 42%. The discussion covers the evolution of immunotherapy through genome sequencing and checkpoint inhibitors, as well as the potential for applying this technology to other cancer types. The conversation also weighs the promise of treating various solid tumors against the high costs of bespoke treatments, while exploring research into 'off-the-shelf' preventative vaccines. Additionally, the episode covers a recent FAA ground stop caused by infrastructure maintenance and an update on the Senate leadership race.

Chapters

Click on a chapter to go directly to that moment

Highlights

really a first-of-its-kind vaccine to treat cancer was shown to work.

00:01:37 · The reporter introduces the primary news regarding the success of a new type of cancer vaccine.

they were able to show that the people who received the vaccine were 42% less likely to have the cancer come back than the people who did not.

00:07:39 · This statistic highlights the significant clinical impact observed in the melanoma vaccine trial.

these are basically a class of drugs that take the brakes off of the immune system.

00:12:54 · The reporter explains how immune checkpoint inhibitors function to allow the immune system to attack cancer cells.

Because instead of a company making a vaccine that lots and lots of people can use, they're making a vaccine that is for one person. And by definition, that means it's not going to be super cost efficient, right?

00:16:45 · The speaker explains the economic challenge of producing individualized vaccines compared to mass-produced ones.

Transportation Secretary Sean Duffy blamed work by a contractor to replace an outdated router. That work, Duffy said, caused circuits in the nation's air traffic network, including its radar system, to become overloaded and disrupted.

00:21:54 · This explains the technical cause behind the recent nationwide air travel ground stop.

Episodes

3310-

Finally, a Vaccine for Cancer

This episode explores a breakthrough in cancer treatment involving an individualized mRNA vaccine for melanoma, which has been shown to reduce the risk of recurrence by 42%. The discussion covers the evolution of immunotherapy through genome sequencing and checkpoint inhibitors, as well as the potential for applying this technology to other cancer types. The conversation also weighs the promise of treating various solid tumors against the high costs of bespoke treatments, while exploring research into 'off-the-shelf' preventative vaccines. Additionally, the episode covers a recent FAA ground stop caused by infrastructure maintenance and an update on the Senate leadership race.

16 Nov 2026
3309-

The Ultraviolent, Wildly Successful, Uniquely American Phenomenon of Grand Theft Auto

Michael Barbaro and Zachary Small explore the cultural and financial evolution of the Grand Theft Auto franchise, tracing its journey from a controversial crime simulator to a global phenomenon. The discussion delves into the series' 'sandbox' gameplay mechanics, its satirical take on American life, and historical controversies like the 'hot coffee' incident. The episode also examines the broader economic crisis facing the AAA gaming industry, characterized by skyrocketing production costs, massive layoffs, and the immense technical complexity of modern titles. As the industry faces significant instability, the conversation looks toward the future of high-budget prestige games and the intense secrecy surrounding the development of Grand Theft Auto 6.

15 Nov 2026
3308-

Olivia Wilde Hit Bottom. Here's How She Bounced Back.

In this interview, David Marchese speaks with director and actress Olivia Wilde about her recent film 'The Invite' and her experiences navigating career shifts. They discuss the complexities of identity, the fear of changing one's path, and how personal growth and maturity influence her approach to storytelling and acting. The conversation also explores the emotional complexities of divorce, co-parenting, and finding body confidence through motherhood. Wilde reflects on how media narratives and public scrutiny during the 'Don't Worry Darling' press tour impacted her personal growth, the transition from being valued for physical appearance to intellectual contribution, and the reality of directing as a collective, curatorial process.

14 Nov 2026
3307-

Can Israel’s Opposition Unseat Netanyahu?

This episode explores the political instability in Israel following an election with no clear winner. Jerusalem Bureau Chief David Heptinger discusses the challenges faced by opposition leader Gadi Eisenkot as he attempts to form a coalition government amidst conflicting ideological and ethnic interests. The discussion delves into the complex landscape of Israeli politics, focusing on the potential for a coalition involving Arab parties and the shifting priorities of Arab citizens. It also examines the political risks of partnering with leaders like Mansour Abbas and the deep-seated national security fears among Jewish Israelis.

13 Nov 2026
3306-

What Jensen Huang’s Resignation Will Mean for A.I.

This episode of The Daily explores the potential resignation of NVIDIA CEO Jensen Huang following reports of a second breach of company conduct involving an intimate relationship with a direct report. The discussion examines the implications of his possible ouster on NVIDIA's leadership stability, the lack of a clear successor, and the broader impact on U.S. AI policy regarding chip sales to China. The conversation further investigates the potential for U.S. government intervention through financial stakes to stabilize the company and explores the challenges posed by NVIDIA's unique organizational structure. The segment concludes with news regarding the appointment of an interim CEO.

12 Nov 2026